IκB-β (phospho Ser23) Polyclonal Antibody

Alias:NFKBIB;IKBB;TRIP9;NF-kappa-B inhibitor beta;NF-kappa-BIB;I-kappa-B-beta;IkB-B;IkB-beta;IkappaBbeta;Thyroid receptor-interacting protein 9;TR-interacting protein 9;TRIP-9

CatalogNo:HJRLP0153

Specifications

50μL;100μL

Delivery date

Spot

Target

IκB β

Reactivity

Human,Mouse,Rat

Application - After Update

WB,IHC,IF,ELISA

MW(Observed)

37kD

Host Species

Rabbit

Isotype

IgG

Modify

Phospho

Recommended dilution ratio

WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:40000;Not yet tested in other applications.

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human IkappaB-beta around the phosphorylation site of Ser23. AA range:8-57

Specificity

Phospho-IκB-β (S23) Polyclonal Antibody detects endogenous levels of IκB-β protein only when phosphorylated at S23.

Gene name

NFKBIB

Protein name

NF-kappa-B inhibitor beta

Organism-1

Human